Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct intrabone versus intravenous autologous stem cell transplantation after ASCT
2008-003537-25Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2008
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous hematopoietic stem cells in hematopoietic malignancies (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Short-term hematopoietic regeneration, Transfusion requirements and 3 more. Started Jun 2008; status: completed.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on 2008-003537-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003537-25.